The combination of Lactobacillus acidophilus lysate and anti-CTLA-4 therapy could enhance anti-tumour immunity in a mouse model of colon cancer, accompanied with increased CD8 + T cells and effector memory T cells, but decreased Treg cells and M2 macrophages (106). The gene discussed is CTLA4; the disease is neoplasm.